Canada Markets closed

Arcturus Therapeutics Holdings Inc. (ARCT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
16.84-0.14 (-0.82%)
At close: 04:00PM EDT
16.85 +0.01 (+0.06%)
After hours: 07:42PM EDT
Currency in USD

Valuation Measures4

We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 2.74
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 365.00
52 Week Low 312.12
50-Day Moving Average 322.93
200-Day Moving Average 335.48

Share Statistics

Avg Vol (3 month) 3655.07k
Avg Vol (10 day) 3733.61k
Shares Outstanding 526.36M
Implied Shares Outstanding 6N/A
Float 822.71M
% Held by Insiders 113.90%
% Held by Institutions 176.83%
Shares Short (Apr 28, 2022) 43.05M
Short Ratio (Apr 28, 2022) 44.21
Short % of Float (Apr 28, 2022) 417.92%
Short % of Shares Outstanding (Apr 28, 2022) 411.55%
Shares Short (prior month Mar 30, 2022) 42.59M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 15, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:7
Last Split Date 3Nov 15, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-1,641.33%

Management Effectiveness

Return on Assets (ttm)-29.17%
Return on Equity (ttm)-65.20%

Income Statement

Revenue (ttm)12.36M
Revenue Per Share (ttm)0.47
Quarterly Revenue Growth (yoy)158.90%
Gross Profit (ttm)12.36M
EBITDA -201.66M
Net Income Avi to Common (ttm)-203.67M
Diluted EPS (ttm)-7.55
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)370.49M
Total Cash Per Share (mrq)14.05
Total Debt (mrq)69.15M
Total Debt/Equity (mrq)30.30
Current Ratio (mrq)3.81
Book Value Per Share (mrq)9.83

Cash Flow Statement

Operating Cash Flow (ttm)-135.04M
Levered Free Cash Flow (ttm)-76.44M